Fabrice T. Nyambod.
CV
Publications

Research output

Peer-reviewed papers, first-author manuscripts under review, and work in preparation. Code links go to public repositories on GitHub. Also on ORCID.

No matches. Try a different search.

Published and accepted 6 papers

  1. Medicaid coverage withdrawal and dispensing of glucagon-like peptide-1 receptor agonists for obesity First author
    Nyambod FT, Msemakweli JG, Onesphore M.
    Cureus. 2026. Accepted.
  2. Treatment limitation and risk-adjusted mortality benchmarking in 190 intensive care units in the United States First author
    Nyambod FT, Wagoh A, Onesphore M, Msemakweli JG.
    Cureus. 2026. Accepted.
    Code
  3. Early nocturnal care disruption and the hazard of incident ICU delirium in critically ill adults: a target-trial emulation in MIMIC-IV
    Msemakweli JG, Nyambod FT, Mbogo AJ, Rutabana V, Massawe L, Onesphore M.
    The American Journal of Medicine. 2026. Advance online publication.
    DOI
  4. Between-hospital variation in liberation from invasive mechanical ventilation: consequences of ignoring death as a competing risk
    Msemakweli JG, Onesphore M, Okpanachi V, Nyambod FT.
    Journal of Critical Care. 2026;97:155743.
    DOI Code Blog post
  5. Environmental blood cadmium tracks with albuminuria at concentrations far below ToxCast AC50s
    Msemakweli JG, Mohamed H, Nyambod FT, Onesphore M, Okpanachi V, Mapande I.
    Toxicology and Applied Pharmacology. 2026;517:118040.
    DOI
  6. Pandemic disruptions and post-COVID patterns of antimicrobial resistance-associated notifications in Sweden
    Msemakweli JG, Abeam GAN, Adabe CE, Nyambod FT, Hernani Rodrigo AE, Adaji OG, Okpanachi V.
    Next Research. 2026;9:101687.
    DOI

Under review 9 first-author manuscripts

  1. Sex-divergent trends in early-onset gastrointestinal cancer in the United States, 1999 to 2019: evidence against a purely diagnostic explanation
    Nyambod FT, Msemakweli JG, Claris A, Onesphore M, Okpanachi V.
    Under review, Cancer Epidemiology.
    Preprint (SSRN)
  2. Cumulative intraoperative hypothermic burden, transfusion, and estimated blood loss: a retrospective cohort study
    Nyambod FT, Msemakweli JG, Claris A, Onesphore M, Okpanachi V.
    Under review.
    Preprint Code
  3. β-Lactam allergy labels and antibiotic selection in 50 US intensive care units: a multicenter active-comparator cohort study
    Nyambod FT, Msemakweli JG, Claris A, Onesphore M, Okpanachi V.
    Under review, Journal of Pharmacy Practice.
    Code
  4. Public reporting understated the decline in recorded antipsychotic use in nursing homes after the 2023 schizophrenia coding audit
    Nyambod FT, Msemakweli JG, Claris A, Onesphore M, Okpanachi V.
    Under review, Journal of the American Medical Directors Association.
  5. Data decay and data amnesia: what a survey interruption costs global health surveillance in sub-Saharan Africa
    Nyambod FT, Msemakweli JG, Claris A, Onesphore M, Okpanachi V.
    Under review, PLOS ONE.
    Code
  6. Accelerometer-verified rest onset corrects protocol-timed heart rate recovery in frail older adults after open-heart surgery
    Nyambod FT, Msemakweli JG, Onesphore M, Claris A, Okpanachi V.
    Under review, European Geriatric Medicine.
    Code
  7. Whether delirium was assessed depended on the intensive care unit, not the patient: 110,257 admissions at 208 US hospitals
    Nyambod FT, Msemakweli JG, Claris A, Onesphore M, Okpanachi V.
    Under review, International Journal for Quality in Health Care.
    Code
  8. Patient out-of-pocket costs at lower-priced sites of service in ambulatory inguinal hernia repair
    Nyambod FT, Msemakweli JG, Uzhegova K, Hassab T.
    Under review, The American Journal of Surgery.
  9. Hourly employment classification and complicated presentation of inguinal hernia
    Nyambod FT, Msemakweli JG, Onesphore M, Uzhegova K, Hassab T.
    Under review, Journal of Surgical Research.
    Code

In preparation First author

  1. Detection and resolution of potential safety signals in the US Food and Drug Administration's Adverse Event Reporting System (FAERS), 2012 to 2023
    Nyambod FT, Msemakweli JG, Rizk JG, Alexander GC.
    Code
  2. Conventional disproportionality thresholds flag most negative control drug-event pairs in the FDA Adverse Event Reporting System: an empirical calibration study
    Nyambod FT.
  3. Substitution across ADHD medications in Medicaid after the 2022 amphetamine shortage, 2018 to 2025
    Nyambod FT.
  4. Short-term outcomes of robotic vs laparoscopic vs open non-elective inguinal hernia repair: a national cohort study
    Nyambod FT, Haut ER, Hicks CW, Slidell MB, Hassab T.
  5. Peritoneal cancer index as a selection criterion for HIPEC in mucinous appendiceal cancer
    Nyambod FT, et al.

Conference presentations

  1. Comparative outcomes of robotic, laparoscopic, and open non-elective inguinal hernia repair: a national cohort study
    Nyambod FT, Haut ER, Hicks CW, Slidell MB, Hassab T.
    Poster, Surgical Outcomes Club, Washington, DC, September 26, 2026.
  2. Peritoneal cancer index and patient selection for CRS/HIPEC in mucinous appendix cancer
    Nyambod FT.
    To be presented, Society of Surgical Oncology (SSO) and Advanced Cancer Therapies (ACT), 2027.